Fri, June 1, 2012
Thu, May 31, 2012
Wed, May 30, 2012
Tue, May 29, 2012
Mon, May 28, 2012
Sun, May 27, 2012
Sat, May 26, 2012
Fri, May 25, 2012
[ Fri, May 25th 2012 ] - Market Wire
GenVec Reports Inducement Award
Thu, May 24, 2012
Wed, May 23, 2012
[ Wed, May 23rd 2012 ] - Market Wire
Moody's Upgrades Mylan
Tue, May 22, 2012
Mon, May 21, 2012
Sun, May 20, 2012
Sat, May 19, 2012
Fri, May 18, 2012

Today's Economic Outlook - Report Highlights Amylin Pharmaceuticals, Inc. and Wal-Mart Stores, Inc.


//health-fitness.news-articles.net/content/2012/ .. pharmaceuticals-inc-and-wal-mart-stores-inc.html
Published in Health and Fitness on Friday, May 25th 2012 at 6:10 GMT by Market Wire   Print publication without navigation


May 25, 2012 09:00 ET

Today's Economic Outlook - Report Highlights Amylin Pharmaceuticals, Inc. and Wal-Mart Stores, Inc.

HONG KONG--(Marketwire - May 25, 2012) - Today, [ www.BrightonMarkets.com ] announced new reports highlighting Amylin Pharmaceuticals, Inc. (NASDAQ: [ AMLN ]) and Wal-Mart Stores, Inc. (NYSE: [ WMT ]). Gain market insight with full analysis and research downloads available at [ www.BrightonMarkets.com/index.php?coa=AMLN&cob=WMT ].

Economic fundamentals leading into 2012 have set a generally positive pace with GDP growth likely to pick up through the coming year. However, there are several important caveats to note as the world economy continues to face headwinds and risks weigh to the downside. Positive outlooks are conditional on fiscal policy in payroll taxes and unemployment insurance benefits and upon the easing of the European debt situation. A repeat of volatility experience in 2011 is likely in 2012, as perceptions about the strength of the U.S. economy and the euro zone will vary over time as events unfold.

Despite the current situation, our team continues to identify high momentum situations with growth potential -- there remains strong opportunity within careful discretion.

Brighton Markets is releasing new coverage on Amylin Pharmaceuticals, Inc. for its current position within the healthcare industry. Amylin Pharmaceuticals, Inc. (Amylin) is a biopharmaceutical company focusing on the diabetes and other metabolic diseases through the discovery, development and commercialization of medicines. The Company is marketing two medicines to treat diabetes, BYETTA (exenatide) injection and SYMLIN (pramlintide acetate) injection. The full research report on Amylin Pharmaceuticals, Inc. (NASDAQ: [ AMLN ]) is available here: [ www.BrightonMarkets.com/index.php?coa=AMLN ].

Brighton Markets has released research on Wal-Mart Stores, Inc. for its changing role within the services industry. Wal-Mart Stores, Inc. (Walmart) operates retail stores in various formats around globally. Everyday low prices (EDLP) is the Company's pricing philosophy under, which it price items at a low price everyday. The Company's operates in three business segments: the Walmart U.S. segment, the Walmart International segment, and the Sam's Club segment. The full research report on Wal-Mart Stores, Inc. (NYSE: [ WMT ]) is available here: [ www.BrightonMarkets.com/index.php?cob=WMT ].

About Brighton Markets
Brighton Markets was founded on the guiding principle of providing highly relevant, meaningful, and actionable information direct to investors. Across the investment spectrum, Brighton Markets shines light on today's events.



Publication Contributing Sources